The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.
This grant program focuses on the development of novel extracellular vesicle (EV)-based therapeutic platforms for regenerative medicine. It aims to support technology development related to the production, manufacturing, and usage of EVs for therapeutic purposes. Key goals include harnessing both native and engineered extracellular vesicles for targeted tissue and organ repair, showcasing the grant's dedication to advancing regenerative medicine through innovative extracellular vesicle-based treatments.